Cargando…
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
Breast cancer is a cancer of high complexity and heterogeneity, with differences in prognosis and survival among patients of different subtypes. Copy number variations (CNVs) within enhancers are crucial drivers of tumorigenesis by influencing expression of their targets. In this study, we performed...
Autores principales: | Zhao, Hongying, Zhang, Siwen, Yin, Xiangzhe, Zhang, Caiyu, Wang, Lixia, Liu, Kailai, Xu, Haotian, Liu, Wangyang, Bo, Lin, Lin, Shihua, Feng, Ke, Lin, Lin, Fei, Meiting, Ning, Shangwei, Wang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592759/ https://www.ncbi.nlm.nih.gov/pubmed/36304471 http://dx.doi.org/10.3389/fimmu.2022.990143 |
Ejemplares similares
-
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
por: Wang, Li, et al.
Publicado: (2022) -
LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases
por: Zhao, Hongying, et al.
Publicado: (2022) -
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023) -
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer
por: Wang, Li, et al.
Publicado: (2022) -
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer
por: Shi, Jian, et al.
Publicado: (2022)